News Release from Allergan Cosmetic Treatments with BOTOX®
Page: 30. DOI: 10.1097/01.NNN.0000311179.44088.6d.. BOTOX® neurotoxin has since received approval in December 2000 seeking the treatment of cervical dystonia in adults to decrease the severity of abnormal cranium attitude and neck suffering associated with cervical dystonia. . A unsophisticated unrecognized occasion of cervical dystonia is trauma such as a motor vehicle accident, a fall, whiplash, etc. However medications can escort to what we call a “ secondary dystonia “ . But more on that later ! . Journal of Pharmacy Practice.. STUDY DESIGN: We story on a 46-year-old chap with atlantoaxial rotatory subluxation and cranio-cervical osseous fusion secondary to cervical dystonia (CD) and concomitant ankylosing spondylitis (AS). OBJECTIVE: To describe treatment of . Additionally, under a separate label, BOTOX® has been approved seeking more than 18 years to treat serious medical conditions such as cervical dystonia, strabismus (crossed eyes), and blepharospasm (uncontrollable blinking). . Cervical dystonia, the most everyday order of focal dystonia, is characterized by face abnormal squeezing and twisting muscle contractions in the cranium and neck area. Sustained muscle contractions consequence in abnormal positions or posturing. . STUDY DESIGN: We story on a 46-year-old chap with atlantoaxial rotatory subluxation and cranio-cervical osseous fusion secondary to cervical dystonia (CD) and concomitant ankylosing spondylitis (AS). OBJECTIVE: To describe treatment of . BOTOX® neurotoxin has since received approval in December 2000 seeking the treatment of cervical dystonia in adults to decrease the severity of abnormal cranium attitude and neck suffering associated with cervical dystonia. . STUDY DESIGN: We story on a 46-year-old chap with atlantoaxial rotatory subluxation and cranio-cervical osseous fusion secondary to cervical dystonia (CD) and concomitant ankylosing spondylitis (AS). OBJECTIVE: To describe treatment of .
Labels: from, Release, Treatments

0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home